Global Cord Blood
CORBF
$1.23
Share price
0.00%
Change (1 day)
17.14%
Change (1 year)
Categories
P/S ratio for Global Cord Blood (CORBF)
P/S ratio as of June 2024 (TTM): 0.8497
According to Global Cord Blood's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.849656. At the end of 2022 the company had a P/S ratio of 2.41.
P/S ratio history for Global Cord Blood from 2010 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 2.41 | -8.51% |
| 2021 | 2.64 | -1.47% |
| 2020 | 2.68 | -25.43% |
| 2019 | 3.59 | -33.44% |
| 2018 | 5.39 | -35.4% |
| 2017 | 8.35 | 99.88% |
| 2016 | 4.18 | -4.67% |
| 2015 | 4.38 | 34% |
| 2014 | 3.27 | 1.08% |
| 2013 | 3.24 | 33.13% |
| 2012 | 2.43 | -27.15% |
| 2011 | 3.34 | -48.22% |
| 2010 | 6.44 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | 2.57 | 202.54% | 🇺🇸 USA |
 National Healthcare
NHC | 1.41 | 65.66% | 🇺🇸 USA |
 NeoGenomics
NEO | 2.74 | 221.96% | 🇺🇸 USA |
 Cryo-Cell CCEL | 2.16 | 154.19% | 🇺🇸 USA |